Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Withdrawn 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Carcinoma, Non-Small-Cell Lung 84Breast Neoplasms 34Colorectal Neoplasms 26Lung Neoplasms 23Rectal Neoplasms 22Neoplasms 21Esophageal Squamous Cell Carcinoma 20Neoplasm Metastasis 19Esophageal Neoplasms 19Head and Neck Neoplasms 17Stomach Neoplasms 15Pancreatic Neoplasms 15Squamous Cell Carcinoma of Head and Neck 14Triple Negative Breast Neoplasms 12Small Cell Lung Carcinoma 12Ovarian Neoplasms 11Recurrence 10Nasopharyngeal Carcinoma 10Carcinoma, Squamous Cell 10Uterine Cervical Neoplasms 9Leukemia, Myeloid, Acute 9Colonic Neoplasms 9Glioblastoma 8Prostatic Neoplasms 7Lymphoma, Large B-Cell, Diffuse 7Lymphoma 7Sarcoma 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Melanoma 6Lymphoma, Non-Hodgkin 6

Interventions

Cytarabine 30Filgrastim 12Daunorubicin 11Busulfan 11Idarubicin 10Peripheral Blood Stem Cell Transplantation 9Etoposide 9fludarabine phosphate 8Mitoxantrone 7Methotrexate 7Gemtuzumab 7sargramostim 6Cyclosporine 6Decitabine 5Cyclophosphamide 5Azacitidine 5Antilymphocyte Serum 5tipifarnib 4alvocidib 4Tacrolimus 4Whole-Body Irradiation 3Vorinostat 3Radiotherapy 3Mycophenolic Acid 3Injections 3Granulocyte Colony-Stimulating Factor 3Clofarabine 3Biopsy 3merphos 2entinostat 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Leukemia, Myelomonocytic, Acute × Drug Therapy × Clear all
NCT00101140 2017-10-19

Donor Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia in Remission

Eastern Cooperative Oncology Group

Phase 2 Withdrawn
Other hematologic neoplasm

Congenital Abnormalities, Leukemia, Erythroblastic, Acute, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡